Sulfonylureas stimulate insulin secretion by blocking ATP-sensitive K+ channels (K+-ATP channels) of the beta-cell membrane, thereby causing depolarization, Ca2+ influx, and rise in cytoplasmic Ca2+ concentration ([Ca2+]i), whereas diazoxide inhibits insulin secretion by opening K+-ATP channels. It has been suggested recently that these drugs also respectively increase and decrease the efficacy of Ca2+ on exocytosis. This hypothesis was tested here with intact islets or single beta-cells from normal mice 
Exocytosis of insulin granules from single, voltage-clamped ␤-cells was also studied by measuring cell capacitance changes. In the perforated patch configuration, exocytosis was evoked by depolarizing pulses. Addition of tolbutamide to the extracellular medium did not aff e c t the Ca 2 + current and the resulting change in cell capacitance. In the whole-cell configuration, cell capacitance increased with the concentration of free Ca 2 + in the solution diffusing from the pipette into the cell. It was markedly potentiated by cAMP, was inhibited by activation of ␣ 2 -adrenoceptors with clonidine, and was strongly augmented by acetylcholine. In contrast, tolbutamide was ineffective whether applied intra-or e x t r a c e l l u l a r l y, at low or high free Ca 2 + , and with or without cAMP. Diazoxide also failed to interfere directly with exocytosis. These results indicate that tolbutamide and diazoxide affect insulin secretion by changing the concentration, not the action, of Ca 2 + in ␤-cells. D i a b e t e s 47:365-373, 1998 G lucose stimulates insulin secretion by two mechanisms that are respectively dependent and independent of ATP-sensitive K + channels (K + -AT P channels). By closing these channels in the plasma membrane of ␤-cells, glucose initiates the following sequence of events: membrane depolarization, opening of voltage-dependent Ca 2 + channels, Ca 2 + i n flux, and rise in cytoplasmic Ca 2 + ( [ C a
2 + ] i ), which constitutes the triggering signal for exocytosis of insulin granules (1-4). The second mechanism does not involve further changes in [Ca 2 + ] i but an increase in the efficacy of Ca 2 + on exocytosis, through as-yetu n i d e n t i fied pathways (5-7).
Hypoglycemic sulfonylureas remain the only useful drugs to increase a deficient insulin secretion and, therefore, are a cornerstone of the pharmacological treatment of type 2 diabetes (8). They largely mimic the effects of glucose in the generation of the triggering signal (9-11). However, a major difference between both secretagogues is that the closure of K + -ATP channels by sulfonylureas does not result from changes in ␤-cell metabolism but from a direct interaction with the sulfonylurea receptor (12,13), which is a subunit of the K + -AT P channel (14, 15) . Activation of a Cl -channel and inhibition of the Na + pump might also contribute to the depolarizationmediated rise in [Ca 2 + ] i brought about by sulfonylureas (10). R e c e n t l y, it has been suggested that sulfonylureas also increase insulin release by a second, very different, mechanism which, like that of glucose, does not involve a rise in [ C a In contrast with these results, we previously failed to confir m that tolbutamide and glibenclamide are effective secretagogues in permeabilized islet cells and to find evidence that they can increase insulin secretion from intact islets when they do not increase [Ca 2 + ] i ( 2 3 ) . In this study, we have pursued the investigation of the question for several reasons. First, it is not known whether the newly proposed mechanism of inhibition of insulin secretion by diazoxide also exists in intact cells. Second, it is crucial to know whether sulfonylureas have one or two modes of action and, therefore, whether they may be expected to partially or completely correct defects in glucose regulation of insulin release. Third, identification of a K + -ATP channel-independent mode of action of sulfonylureas and diazoxide would considerably help in elucidating the second pathway of regulation by glucose. The experiments were performed with normal mouse islets in which the effects of tolbutamide and diazoxide on [Ca 2 + ] i and insulin secretion were compared. The effects of the drugs on exocytosis were also estimated by recording capacitance changes in single ␤-cells, the electrophysiological technique that was previously used to identify their novel mode of action (17, 22) .
RESEARCH DESIGN AND METHODS
Preparation. Islets were isolated by collagenase digestion of the pancreas of fed female NMRI mice (25-30 g), followed by hand-picking. They were then cultured in RPMI 1640 medium (Gibco BRL, Paisley, Scotland, U.K.) containing 10 mmol/l glucose, 10% heat-inactivated fetal calf serum, 100 IU/ml penicillin, and 100 µg/ml streptomycin. For patch-clamp experiments, the islets were dispersed into single cells with a Ca 2 + -free buffer containing 100 µmol/l EGTA and 100 µg/ml trypsin. The cells were then cultured in the same medium as above. ␤-Cells make up about 80% of islet cells in normal mice (24) and have a larger diameter (11-14 µm) than do ␣-cells (8-11 µm) (25). The cells used for the electrophysiological experiments were selected for their large size. From their basal capacitance (~ 6pF) and a specific membrane capacitance of 10 fF/µm 2 , one can recalculate that these cells had a diameter of about 13-14 µm. Solutions. The medium used for islet isolation was a bicarbonate-buffered solution that contained 120 mmol/l NaCl, 4.8 mmol/l KCl, 2.5 mmol/l CaCl 2 , 1.2 mmol/l M g C l 2 , and 24 mmol/l NaHCO 3 . It was gassed with O 2 : C O 2 (94:6) to maintain pH 7.4 and was supplemented with bovine serum albumin (1 mg/ml). A similar medium was used for measurements of [Ca 2 + ] i and insulin secretion. When the concentration of KCl was increased to 15, 30, or 60 mmol/l, that of NaCl was decreased accordingly to maintain iso-osmolarity. When the concentration of CaCl 2 was decreased to 0.5 mmol/l, that of MgCl 2 was increased from 1.2 to 3.2 mmol/l. To l b u t a m i d e (Sigma, St. Louis, MO) and diazoxide (Schering-Plough Avondale, Rathdrum, Ireland) were added to the medium from stock solutions in NaOH.
For electrophysiological experiments, different types of solutions were used depending on the mode of recording. For whole-cell recordings, the extracellular medium (pH 7.4) contained 145 mmol/l NaCl, 4.8 mmol/l KCl, 3.7 mmol/l M g C l 2 , 0.1 mmol/l EGTA, 10 mmol/l HEPES, and 20 mmol/l glucose (5 mmol/l in the experiments without cAMP shown in Fig. 4 ). Under these conditions, only the C a 2 + buffer present in the pipette solution can activate secretion; and if there were even a slight inward current, it could not be carried by Ca 2 + . The pipette solution (pH 7.2) contained 135 mmol/l K-gluconate; 10 mmol/l EGTA; 4 mmol/l MgCl 2 ; 5 mmol/l HEPES; 3 mmol/l ATP; 0 or 0.1 mmol/l GTP; 0, 0.1, or 1 mmol/l cAMP; and 6 or 9 mmol/l CaCl 2 (to give 0.2 and 1.25 µmol/l free Ca 2 + , respectively, as calculated by the software Calc, version 2.2). For perforated-patch recordings, the extracellular medium contained 125 mmol/l NaCl, 20 mmol/l TEA-Cl, 5 mmol/l CaCl 2 , 1.2 mmol/l MgCl 2 , 10 mmol/l HEPES, 20 mmol/l glucose, and 2 µmol/l forskolin. The pipette solution contained 76 mmol/l Cs 2 S O 4 , 35 mmol/l CsCl, 10 mmol/l NaCl, 10 mmol/l KCl, 1 mmol/l MgCl 2 , and 5 mmol/l HEPES.
Measurements of [Ca
2 + ] i . Islets were cultured on glass coverslips to which they readily attached. After 1-2 days, the coverslip was placed into a bicarbonate medium containing 10 mmol/l glucose and supplemented with 2 µmol/l fura PE3/AM (Te flabs, Austin, TX) for 120 min of incubation at 37°C. Islets loaded with the Ca 2 + dye were then transferred into a temperature-controlled perifusion chamber (Intracell, Royston, Herts, U.K.) of which the coverslip formed the bottom. The preparation was then perifused at a flow rate of 1.3 ml/min. The solutions were kept at 38°C in a water bath, and a temperature controller ensured a temperature of 37°C (±0.3°C) in the chamber as monitored by a thermistor.
The measurements of [Ca 2 + ] i were performed with the MagiCal system (Applied Imaging, Sunderland, U.K.) as described in detail (21). The tissue was excited at 340 nm and 380 nm. The fluorescence emitted at 510 nm was captured by a CCD video camera (Photonic Science, Tunbridge Wells, U.K.). From the ratio of the fluorescence at 340 and 380 nm, the concentration of [Ca 2 + ] i was calculated by comparison with a calibration curve (21). Measurements of insulin secretion. After 1 day of culture, the islets were preincubated for 60 min at 37°C in a bicarbonate medium containing 10 mmol/l glucose. Batches of 20 islets were then placed in parallel perifusion chambers and perifused at a flow rate of 1.2 ml/min (26). Effluent fractions collected at 2-min intervals were chilled until their insulin content was measured by a double-antibody radioimmunoassay with rat insulin as the standard (Novo Research Institute, Bagsvaerd, Denmark). Measurements of ␤-cell membrane capacitance. Patch-clamp experiments were performed at 33°C, in the conventional whole-cell recording configuration or in perforated mode, using an EPC9 patch-clamp amplifier (HEKA Electronics, Lambrecht/Pfalz, Germany). Cultured cells were first preincubated for 30 min in the presence of 10 µmol/l forskolin and then perifused at a rate of 1 ml/min. The bath and pipette solutions were as described above. Patch pipettes were pulled from glass capillaries (Clark Electromedical Instruments, Reading, U.K.) to give a resistance of 2-3 M⍀ after coating with Sylgard (Dow Corning, Wiesbaden, Germany) and fir epolishing. For recordings in perforated patch-configuration, pipettes were dipped for a few seconds in the pipette solution free of amphotericin B and then back-fil l e d with the same solution containing 250 µg amphotericin B/ml. Perforation usually occurred progressively, in less than 5 min. The access conductance was considered large enough to begin capacitance measurements when exceeding 30 nS.
To assay exocytosis, membrane capacitance was measured with a technique derived from the phase-sensitive method (27). A 830-Hz sinewave with a peak-topeak amplitude of 30 mV was applied to the cell under voltage-clamp conditions (-70 mV), and the resulting membrane current was filtered at 3 kHz with a 4-pole Bessel fil t e r. The membrane capacitance (C m ) and conductance (G m ) and the access conductance (G a ) were derived from analysis of the sinusoidal membrane current at two orthogonal phase angles. This was done with the Lockin extension of the Pulse 8.09 software (HEKA Electronics) using the "sine + dc" protocol derived from the method referred to as "computer-aided reconstruction of passive cell parameters" by Lindau and Neher (28, 29) . The reversal potential of the DC current was assumed to be 0. Protocols of 8 cycles (9.6 ms in total) were applied to the cell every 100 ms. A single value of each membrane parameter (C m , G m , and G a ) was computed each cycle; an average value was calculated from the 8 values and eventually sent to the XChart Software (HEKA Electronics). From an initial sampling frequency of 50 kHz for the sinusoidal membrane current, this gave a fin a l frequency acquisition of 10 Hz for capacitance measurements using XChart.
In the perforated mode, exocytosis was triggered by applying voltage steps. Every 2 min, the XChart trace was temporarily interrupted to apply a voltage pulse from Pulse 8.09. This protocol was composed of a control period of 50 ms during which C m , G m , and G a were measured every cycle, a voltage step to 0 mV for 500 ms, and a 1-s period during which C m , G m , and G a were measured every cycle again. This gave a high temporal resolution of C m , 833 Hz against 10 kHz for the membrane current during the whole protocol. Membrane capacitance increases after depolarization were calculated 1 s after the end of the voltage pulse to avoid contamination by gating charge movements or tail currents. Then measurements with XChart at a low temporal resolution (10 Hz) were automatically resumed. Only traces analyzed from XChart at a low temporal resolution are shown in this study.
In standard whole-cell recording, exocytosis was stimulated by the high concentration of free Ca 2 + (0.2 or 1.25 µmol/l) in the medium diffusing from the pipette into the cell interior. Measurements of C m were performed with the above protocol as long as the cell secreted and until C m reached a plateau.
The exocytotic responses were estimated as maximum changes in cell capacitance (⌬C m ) and, for whole-cell recordings, as rates of capacitance changes ( dC m / dt) calculated during the first min or between 20 and 80% of the C m v a r i ation induced by the stimulus. Statistical analysis. Results are usually presented as means ± SE. For [Ca 2 + ] i measurements, recordings were obtained with five or six individual islets from each preparation. The same experiment was repeated with three or four distinct islet preparations. For insulin release, each protocol was tested with islets from six to nine different preparations. For electrophysiological recordings, experiments were repeated on two to four different batches of cells. Results were compared with a paired or unpaired t test, according to the type of experiment. (Fig. 1,  lower panels) .
R E S U LT
To determine whether this lack of effect is due to membrane depolarization or to high [Ca 2 + ] i , the effects of tolbutamide were also tested in a medium containing 60 mmol/l K + and 0.5 instead of 2.5 mmol/l CaCl 2 (Fig. 1, lower panels) . Under these conditions, both [Ca 2 + ] i and the insulin secretion rate were between those recorded in the presence of 4.8 and 15 mmol/l K + , but tolbutamide was again without effect. Similar experiments (n = 7) were also performed in the presence of 0.5 mmol/l dibutyryl cAMP. Control [Ca 2 + ] i was not affected, but control insulin secretion was increased by ~80% (293 ± 39 vs. 162 ± 16 pg · islet -1 · min -1 ). This, however, did not disclose any effect of tolbutamide (not shown). E ffects of tolbutamide in the presence of meglitinide. Meglitinide, also known as compound HB 699, is the nonsulfonylurea moiety of glibenclamide. It increases insulin secretion by binding to the sulfonylurea receptor and blocking K + -ATP channels as do tolbutamide and glibenclamide (13, 31, 32) . Repaglinide, a parent compound of meglitinide, has been reported not to possess the second effect of sulfonylureas (33). This means that by virtue of its action on the Ca to 306 ± 18 nmol/l (n = 18) and the insulin secretion rate to 294 ± 27 pg · islet -1 · min -1 (n = 7). Subsequent addition of 100 µmol/l tolbutamide had no effect on [Ca 2 + ] i and insulin secretion (not shown). E ffects of tolbutamide on ␤-cell capacitance changes studied in intact ␤-cells. Whole-cell Ca 2 + current and cell capacitance were measured using the perforated-patch, whole-cell configuration. The mean basal cell capacitance averaged 6.89 ± 0.31 pF. Under control conditions, 500-ms depolarizations from -70 to 0 mV evoked Ca 2 + currents of about 200 pA at the peak and capacitance increases that averaged about 80 fF ( Fig. 2A) . When the stimulation was repeated every 2 min up to 10 min after the addition of 100 µmol/l tolbutamide to the bath, the amplitude of the Ca 2 + c u rrent remained fairly stable, and the evoked capacitance change was not significantly affected (Fig. 2B) . In contrast, the increase in capacitance was tripled after 6 min of treatment with 25 nmol/l phorbol 12-myristate 13-acetate to activate protein kinase C (not shown). Validation of the whole-cell configuration to study exocytosis by cell capacitance. The mean initial cell capacitance (C m ) recorded upon rupture of the ␤-cell membrane averaged 6.52 ± 0.13 pF. A progressive increase in C m f o l l o w e d diffusion into the cell of the pipette solution containing 1.25 µmol/l free Ca 2 + (Fig. 3A) . Both the magnitude and the rate of the changes were markedly increased by cAMP (Fig. 3A) . 
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both its extent and rate were augmented by the presence of 100 µmol/l acetylcholine (ACh) in the extracellular solution (Fig. 3B) . In contrast, the response evoked by 1.25 µmol/l free C a 2 + was strongly inhibited by clonidine (Fig. 3C) . These results thus show that exocytosis studied with this technique is Ca 2 + dependent, increased by cAMP, and sensitive to potentiation and inhibition by activation of muscarinic and ␣ 2 -adrenergic receptors, respectively. E ffects of tolbutamide on cell capacitance in the presence of 0.2 µmol/l intracellular Ca 2 + . When ␤-cells were dialysed with a pipette solution containing 0.2 µmol/l Ca 2 + a n d 1 mmol/l cAMP, an increase in cell capacitance averaging about 1 pF was recorded (Fig. 4A) . The presence of 100 µmol/l tolbutamide in the pipette solution or in the bath solution (which was devoid of CaCl 2 ) had no effect on the maximum change in cell capacitance. The rate of change in cell capacitance (dC m / dt) was also unaffected by tolbutamide, whether it was calculated between 20 and 80% of the changes (Fig. 4A, bottom) or during the 1st min of change: 6.6 ± 1.2, 7.5 ± 1.6, and 6.0 ± 1.6 fF/s for controls, To l b i , or To l b 0 , respect i v e l y. Unlike ACh, tolbutamide was also ineffective when added to the bath after the increase in cell capacitance had developed in response to Ca 2 + and cAMP (Fig. 4B, bottom) . When the experiments were carried out in the presence of 0.2 µmol/l Ca 2 + and the absence of cAMP, cell capacitance did not s i g n i ficantly change in the absence or presence of tolbutamide in the pipette (Fig. 4B ) . E ffects of tolbutamide on cell capacitance in the presence of 1.25 µmol/l intracellular Ca 2 + . In control cells, the maximum increase and the rate of change in cell capacitance evoked by 1.25 µmol/l Ca 2 + augmented with the concentration of cAMP, but they were not significantly affected by the presence of 100 µmol/l tolbutamide in the pipette solution (Figs.  5A and B) . Addition of tolbutamide to the bath solution was also ineffective under these conditions (data not shown). ] i nor insulin secretion was affected by diazoxide in the presence of 60 mmol/l K + , irrespective of the Ca 2 + c o n c e ntration in the medium and, hence, of the degree of ␤-c e l l stimulation (Fig. 6, lower panels) . E ffects of diazoxide on cell capacitance in the presence of 1.25 µmol/l intracellular Ca 2 + . The presence of 250 µmol/l diazoxide in the pipette solution was without effect on the maximum change (⌬C m ) in cell capacitance evoked by 1.25 µmol/l Ca 2 + in the presence of 1 mmol/l cAMP (Fig. 5C ) . The rate of change in cell capacitance (dC m / dt) was also unaffected by diazoxide, whether it was calculated between 20 and 80% of the changes (Fig. 5C, bottom) or during the 1st min of change: 12.9 ± 2.7 and 11.9 ± 1.7 fF/s without and with diazoxide, respectively.
D I S C U S S I O N
There is no dispute that K + -ATP channels are the primary site of action of tolbutamide and diazoxide in ␤-cells. Their closure and opening eventually increase and decrease [Ca 2 + ] i , leading to stimulation and inhibition of insulin secretion, r e s p e c t i v e l y. The question addressed in this study was whether these drugs also affect secretion by modulating the action of Ca 2 + on the exocytotic process. To test the hypothesis, it is essential that [Ca 2 + ] i remains stable because any change might account for an accompanying change in secretion. This is not easy in intact islets, the use of which is, however, essential to ascertain the physiological relevance of observations made with indirect approaches. When islets are studied in a control medium (4.8 mmol/l K + , 15 mmol/l glucose), the blockade of K + -ATP channels by tolbutamide causes depolarization, rise in [ C a 2 + ] i , and stimulation of insulin release (9-12). The latter two events were measured in this study. Raising the concentration of K + in the medium to depolarize the ␤-c e l l membrane (30) ] i and secretion. Exocytosis can be studied at the single-cell level by monitoring changes in cell capacitance (27) (28) (29) . Because cell capacitance is proportional to cell surface area, and because the latter increases after fusion with secretory vesicles during exocytosis, secretion is detected by increases in cell capacitance. Conversely, endocytosis is followed by decreases in cell capacitance, and the measured changes are the net result of both processes. The technique has already been successfully applied to studies of insulin secretion from single ␤-cells (34-38).
With the perforated-patch technique, the cell remains intact and exocytosis is triggered by depolarizing pulses that activate Ca 2 + i n flux through voltage-dependent Ca 2 + c h a nnels. These experiments were carried out in the presence of forskolin because the capacitance changes evoked by C a 2 + i n flux are small if cAMP levels are low in ␤-cells (35,36; P.M., unpublished observations). Under these conditions, depolarizations for 500 ms to 0 mV evoked increases in cell capacitance similar to those reported by others (17, 35, 36) . H o w e v e r, tolbutamide failed to increase the response, which contrasts with the doubling of the response that a similar concentration of the sulfonylurea produced in another study using similar tissue and conditions (17).
Cell capacitance changes can also be measured in the standard whole-cell configuration (37, 38) . After rupture of the plasma membrane at the tip of the recording pipette, the solution contained in the pipette diffuses within the cell and, if appropriate, stimulates exocytosis. Our results show that cell capacitance increased with the concentration of free Ca 2 + (38), was markedly potentiated by cAMP, was inhibited by activation of ␣ 2 -adrenoceptors with clonidine (39), and was strongly augmented by acetylcholine. In spite of this evidence that our experimental model functions adequately, being able to detect receptor-mediated changes in exocytosis, tolbutamide was again found to be without effect. In a recent study, as yet reported in abstract form only (22) , with or without cAMP. Whether the drug had a net effect on exocytosis (total change in capacitance) was not reported in the abstract (22).
Like those of tolbutamide, the effects of diazoxide on insulin secretion from intact islets have been studied during perifusions with solutions containing various K + c o n c e n t r ations. The drug was found to inhibit secretion as long as it also decreased [Ca 2 + ] i in islet cells. If diazoxide were able to interfere with the action of Ca 2 + on exocytosis, it should have inhibited insulin secretion in the presence of 60 mmol/l K + even when it failed to lower the moderately (0.5 mmol/l extracellular CaCl 2 ) or markedly (2.5 mmol/l extracellular C a C l 2 ) elevated [Ca 2 + ] i . Our measurements of cell capacitance also failed to disclose any direct inhibition of the exocytotic process by diazoxide applied intracellularly. Thus, they disagree with a previous study reporting that diazoxide strongly reduces the rate of capacitance change induced by tolbutamide or Ca 2 + (22). It should also be borne in mind that many laboratories have reported that, provided glucose is present, high K + stimulates a sustained release of insulin from intact islets in the presence of diazoxide (7, (40) (41) (42) . This would not be so if diazoxide had any strong inhibitory action on exocytosis.
What can be the reason for the disparity between the present and previous results (17,22) based on capacitance measurements? With the reservation that few technical details are given in an abstract (22), comparison of both approaches shows the following important similarities and potentially s i g n i ficant differences. The animal species, the recording temperature, and the concentrations of tolbutamide and forskolin were identical, and the concentration of diazoxide was only slightly different (250 vs. 400 µmol/l). Our solutions contained 20 or 5 mmol/l glucose as compared with 5 or 0 mmol/l glucose (17), but this was not found to make any difference in either study. Finally, two different algorithms were used for capacitance measurements. The technique of Eliasson et al. (17) is based on the classic phase-sensitive method (43), whereas ours is based on a modification of this method (28) that has recently proved to be very reliable with the "Pulse-lockin" EPC-9 software that we used (44). Discussion of the respective advantages and limitations of each technique is beyond the scope of this paper, in particular because both approaches have usually been found to yield qualitatively similar results in other systems. We thus have no explanation for the disparity between our results and those of others, but we insist on the fact that our conclusions rely on data obtained with several methodologies.
By using three approaches to study insulin secretion, direct measurements from intact islets perifused for several minutes or from incubated permeabilized islet cells (23) and indirect estimations of exocytosis by recording cell capacitance changes during a few seconds or minutes, we conclude that tolbutamide and diazoxide affect secretion by changing the concentration, not the action, of Ca 2 + in ␤-cells. If the latter effect exists, as suggested by others (16, 17, 22) , it must be short-lived and small enough to escape our detection, and it is unlikely to be therapeutically relevant. There is no evidence that sulfonylureas mimic the second mechanism by which glucose stimulates insulin secretion (5-7). This just i fies ongoing searches for new drugs acting on ␤-c e l l s . 
